NASDAQ:PRQR

Analyst Snapshot

ProQR Therapeutics N.V (PRQR) is a good investment, but the stock may be overvalued

Cameron Mitchell

While ProQR Therapeutics N.V has overperformed by 4.43%, investors are advised to look at stock chart patterns for technical insight. ...

Analyst Snapshot

ProQR Therapeutics N.V (PRQR)’s stock decline to 2.1 per share

Kenneth Phillips

While ProQR Therapeutics N.V has underperformed by -2.78%, investors are advised to look at stock chart patterns for technical insight. ...

Financial Scores

ProQR Therapeutics N.V PRQR’s stock price falss traction on Friday

Cameron Mitchell

While ProQR Therapeutics N.V has underperformed by -1.27%, investors are advised to look at stock chart patterns for technical insight. ...

US Post News
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.